Detection of BCR/PDGRFα Fusion Using Dual Colour Dual Fusion BCR/ABL1 Probe: An Illustrative Report

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Beau MML et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405 Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Blood 129(6):704–714 Baxter EJ, Hochhaus A, Bolufer P, Reiter A, Fernandez JM, Senent L et al (2002) The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA. Hum Mol Genet 11(12):1391–1397 Trempat P, Villalva C, Laurent G, Armstrong F, Delsol G, Dastugue N et al (2003) Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec. Oncogene 22(36):5702–5706 Safley AM, Sebastian S, Collins TS, Tirado CA, Stenzel TT, Gong JZ et al (2004) Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia. Genes Chromosomes Cancer 40(1):44–50 Erben P, Gosenca D, Muller MC, Relnhard J, Score J, Valle F et al (2010) Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica 95(5):738–744 Wang HY, Thorson JA, Broome HE, Rashidi HH, Curtin PC, Dell’Aquila ML (2011) t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia. Hum Pathol 42:2029–2036 Yigit N, Wu WW, Subramaniyam S, Mathew S, Geyer JT (2015) BCR–PDGFRA fusion in a T lymphoblastic leukemia/lymphoma. Cancer Genet 208(7):404–407